Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Eitemau Tebyg

• Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
  gan: Oh, Felix, et al.
  Cyhoeddwyd: (2020)
• Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
  gan: Borgatti, Antonella, et al.
  Cyhoeddwyd: (2017)
• A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
  gan: Tsai, Alexander K., et al.
  Cyhoeddwyd: (2010)
• Bispecific Targeting of EGFR and uPAR in a Mouse Model of Head and Neck Squamous Cell Carcinoma
  gan: Waldron, Nate N., et al.
  Cyhoeddwyd: (2012)
• uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
  gan: Biagioni, Alessio, et al.
  Cyhoeddwyd: (2020)